Luis Esteves Flores
Novartis (Spain)(ES)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Sarcoma Diagnosis and Treatment, Reconstructive Surgery and Microvascular Techniques
Most-Cited Works
- → Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action(2016)102 cited
- → The role of mTOR inhibition as second-line therapy in metastatic renal carcinoma: clinical evidence and current challenges(2017)6 cited
- → The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma(2016)6 cited
- → Carcinoma primario de la trompa de falopio(2015)3 cited
- → Carcinoma basocelular de la vulva(2015)1 cited
- → Cirugía radical en el cáncer ginecológico(2015)
- → Cost Comparison in the Management of Adult Patients with Advanced Soft Tissue Sarcoma Previously Treated in Spain: Pazopanib vs. Trabectedina(2016)
- → Tratamiento quirúrgico del cáncer avanzado de cuello uterino(2015)
- → Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain: Pazopanib vs. Sunitinib(2016)